Use of promethazine, gabapentin and clonidine in combination with opioids or opioid agonist therapies among individuals attending a syringe service program-Reference-Cited by-同舟云学术

Use of promethazine, gabapentin and clonidine in combination with opioids or opioid agonist therapies among individuals attending a syringe service program

Published:2020-05 Issue: Volume:79 Page:102752
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Applewhite Dinah,Regan Susan,Koenigs Kathleen,Mackin Sarah,Schmidt Clare,Wakeman Sarah E.

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference34 articles.

1. Gabapentinoid abuse in order to potentiate the effect of methadone: A survey among substance misusers;Baird;European Addiction Research,2014

2. Arguments supporting and opposing legalization of safe consumption sites in the US;Barry;International Journal of Drug Policy,2019

3. Opioids and cardiac arrhythmia: A literature review;Behzadi;Medical principles and practice : International Journal of the Kuwait University, Health Science Centre,2018

4. Today's fentanyl crisis: Prohibition's iron law, revisited;Beletsky;International Journal of Drug Policy,2017

5. Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers;Buttram;Journal of Substance Abuse Treatment,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality;International Journal of Drug Policy;2024-01

2. Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs;The American Journal on Addictions;2023-09-17

3. Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review;Substance Use & Misuse;2023-02-20

4. Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability;The Journal of Clinical Pharmacology;2021-08

5. Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”;Pain and Therapy;2021-02-09